All Health Focuses

PCOS

You've got a diagnosis of Polycystic Ovarian Syndrome. Here's what the research says about food and PCOS.

Polycystic Ovary Syndrome (PCOS) is one of the most common hormonal conditions affecting people with ovaries. It's characterized by hormonal imbalance, irregular or absent menstrual cycles, and in many cases, changes in how the body responds to insulin.

This meal plan is designed specifically for the insulin-resistant subtype of PCOS, the most prevalent presentation. If you're not sure whether this applies to you, speak with your healthcare provider about whether this plan is the right fit.

The Research: Macros, Adjunctive Foods & Guiding Principles

Macronutrient Framework

Research suggests that overall caloric balance plays a meaningful role in managing insulin-resistant PCOS, with modest improvements in insulin sensitivity observed even with small reductions in energy intake. The specific macro distribution matters less than consistency with a quality whole-food pattern over time. We use a practical macro range that tends to work well for satiety and glycemic stability of 20–30% protein, 35–45% carbohydrates, and 25–35% fat.

Carbohydrates: The plan prioritises low glycemic index (GI) carbohydrates, which may improve insulin sensitivity and reduce androgen levels compared to higher GI diets.

Protein: Higher protein intake supports satiety and blood glucose stability, with some research showing improvements in fasting insulin and body composition in women with PCOS.

Fat: The plan emphasises unsaturated, anti-inflammatory fats. Omega-3 fatty acids and monounsaturated fats which may support lipid and inflammatory markers in PCOS.

Adjunctive Nutrition Strategies

The following foods are woven throughout this plan based on their specific evidence in PCOS and metabolic health.

Cinnamon: A tasty spice, with some research trials suggesting modest improvements in insulin markers.

Ground flaxseed: Provides lignans and soluble fibre, with evidence suggesting reductions in androgen levels and support for hormonal balance.

Nuts: Tree nut consumption is associated with improved insulin resistance and reduced inflammatory markers, attributed to their anti-inflammatory fats, magnesium, and fibre content.

Omega-3 fatty acids: Regular intake of omega-3 fatty acids, primarily through oily fish, has shown modest benefits for insulin and androgen markers in some trials.

Adjunctive ingredients are adapted based on individual allergies and food preferences.

Guiding Principles

Mediterranean dietary pattern: The overall structure follows a Mediterranean eating pattern, which has a strong evidence base for improving metabolic and hormonal markers in PCOS.

Soluble fibre: Soluble fibre slows glucose absorption and has been associated with improved insulin sensitivity. The plan is structured to meet daily targets through food sources alone.

Limitations & Safety

Diet is one piece of a larger picture. Nutrition plays a significant and well-researched role in managing insulin-resistant PCOS, but the best outcomes come from a comprehensive treatment plan guided by your healthcare provider. This meal plan is designed to complement, not replace, medical care.

Work with your team. We encourage you to share this plan with your doctor, gynaecologist, or dietitian. They can help you integrate it with any medications or treatments you're already using and monitor your progress over time.

Exercise matters. Physical activity is another evidence-supported strategy for improving insulin sensitivity and blood sugar regulation in people with PCOS. While this plan focuses on nutrition, we recommend working with a qualified exercise professional to develop an approach that complements your dietary changes safely.

Foods and medications. Some foods featured in this plan may interact with certain medications. If you are taking any prescription or over-the-counter medications, speak with your healthcare provider before making significant dietary changes.

This plan is evidence-informed, not individually prescribed. While the plan is built around your inputs and the best available research, it is not a substitute for one-on-one advice from a registered dietitian who can assess your full clinical picture.

Food and feelings. For many people with PCOS, the relationship between food, body image, and hormonal health is emotionally complex. If you find this plan brings up difficult feelings around eating, we encourage you to reach out to a qualified professional for support.

This plan does not cure PCOS, and individual results will vary.

Who This Plan Is Not For

This plan is not appropriate if you are pregnant, under 16, or managing certain overlapping health conditions. See our full eligibility guide for details.

References

  • Barrea, L., et al. (2018). Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome. Nutrition Research Reviews, 31(2), 291–301.
  • Barrea, L., et al. (2019). Adherence to the Mediterranean diet, dietary patterns and body composition in women with polycystic ovary syndrome (PCOS). Nutrients, 11, 2278.
  • Kazemi, M., et al. (2021). Effects of dietary glycemic index and glycemic load on cardiometabolic and reproductive profiles in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. Advances in Nutrition, 12, 161–178.
  • Leung, W. T., et al. (2022). Lower fiber consumption in women with polycystic ovary syndrome: A meta-analysis of observational studies. Nutrients, 14, 5285.
  • Haidari, F., et al. (2020). The effects of flaxseed supplementation on metabolic status in women with polycystic ovary syndrome: A randomized open-labeled controlled clinical trial. Nutrition Journal, 19(1), 8.
  • Hajimonfarednejad, M., et al. (2018). Insulin resistance improvement by cinnamon powder in polycystic ovary syndrome: A randomized double-blind placebo controlled clinical trial. Phytotherapy Research, 32(2), 276–283.
  • Marsh, K. A., et al. (2010). Effect of a low glycemic index compared with a conventional healthy diet on polycystic ovary syndrome. American Journal of Clinical Nutrition, 92(1), 83–92.
  • Mei, S., et al. (2022). Mediterranean diet combined with a low-carbohydrate dietary pattern in the treatment of overweight polycystic ovary syndrome patients. Frontiers in Nutrition, 9, 876620.
  • Najdgholami, Z., et al. (2025). Flaxseed intervention and reproductive endocrine profiles in patients with polycystic ovary syndrome: An open-labeled randomized controlled clinical trial. Frontiers in Endocrinology, 16, 1531762.
  • Rasheed, N., et al. (2023). Effectiveness of combined seeds (pumpkin, sunflower, sesame, flaxseed): As adjacent therapy to treat polycystic ovary syndrome in females. Food Science & Nutrition, 11, 3385–3393.
  • Saadati, N., et al. (2021). The effect of low glycemic index diet on the reproductive and clinical profile in women with polycystic ovarian syndrome: A systematic review and meta-analysis. Heliyon, 7(11), e08338.
  • Teede, H. J., et al. (2018). Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human Reproduction, 33(9), 1602–1618.
  • Yuan, J., et al. (2021). Efficacy of omega-3 polyunsaturated fatty acids on hormones, oxidative stress, and inflammatory parameters among polycystic ovary syndrome: A systematic review and meta-analysis. Annals of Palliative Medicine, 10(8), 8991–9001.
  • Zhou, J., et al. (2023). Effects of n-3 polyunsaturated fatty acid on metabolic status in women with polycystic ovary syndrome: A meta-analysis of randomized controlled trials. Journal of Ovarian Research, 16, 54.

Ready to start eating well?

Create your account and start building your personalized meal plan.

Sign up

This program provides personalized meal planning and nutrition education based on user-selected preferences and nutrition focus areas. Meal plans are generated using standardized nutrition frameworks and reviewed by a licensed Naturopathic Doctor for quality, safety, and alignment with the selected focus. This service does not include medical assessment, diagnosis, or treatment, and does not establish a patient-provider relationship.